Tan, Aidan <br/><br/>
Differences in Treatment Effect Size Between Overall Survival and Progression-Free Survival in Immunotherapy Trials: A Meta-Epidemiologic Study of Trials With Results Posted at ClinicalTrials.gov.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  May 2017 
 - 1686-1694 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2016.71.2109  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Bevacizumab--therapeutic use<br/>Clinical Trials as Topic--methods<br/>Disease-Free Survival<br/>Epidemiologic Studies<br/>Humans<br/>Immunotherapy--methods<br/>Neoplasms--drug therapy<br/>Survival Rate